** Shares in Thales edge down 1.8% after the French defence electronics and cybersecurity company said on Tuesday it had agreed to buy U.S. cybersecurity company Imperva in a deal worth $3.6 billion on an enterprise value basis
** The deal is valued at 6.1x 2024E EV/Sales, 17x 2024E EV/EBIT post synergies and 13x 2027E EV/EBIT post synergies
** "These are punchy multiples for the A&D [Aerospace and Defense - MA] industry but much more typical for the cybersecurity space," says Jefferies
** The brokerage says that key unknowns at this stage are the timing of synergies and implementation costs
** The brokerage notes that synergies are expected to essentially double 2024 EBIT implied at about $100 million, which implies some execution risk
** "We also note that ROCEis only expected to stand above WACC 5 years post closing, and EPS accretion is expected to be "significant" in the medium term, implying some dilution in the early stages", it adds
** Stock on track for worst day since November 2022, among top fallers on France's blue-chip index CAC 40
(Reporting by Michal Aleksandrowicz)
((michal.aleksandrowicz@tr.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.